Kamaljit Chatha

1.2k total citations · 2 hit papers
22 papers, 830 citations indexed

About

Kamaljit Chatha is a scholar working on Epidemiology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Kamaljit Chatha has authored 22 papers receiving a total of 830 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 5 papers in Molecular Biology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Kamaljit Chatha's work include Liver Disease Diagnosis and Treatment (4 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Kamaljit Chatha is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Kamaljit Chatha collaborates with scholars based in United Kingdom, Greece and United States. Kamaljit Chatha's co-authors include Harpal Randeva, Ioannis Kyrou, Emmanouíl Karteris, Demetrios�� Spandidos, Marcia Hall, Eva Kassi, Julie Davies, Konstantinos Kontzoglou, Antonios Chatzigeorgiou and Narjes Nasiri‐Ansari and has published in prestigious journals such as Proceedings of the National Academy of Sciences, International Journal of Molecular Sciences and Journal of Clinical Pathology.

In The Last Decade

Kamaljit Chatha

21 papers receiving 815 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE(-/-) Mice by Activating Autophagy and Reducing ER Stress and Apoptosis

2021 234 citations Narjes Nasiri‐Ansari, Ioannis Kyrou et al. International Journal of Molecular Sciences profile →
Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD

2024 53 citations Chris Kite, Kamaljit Chatha et al. Current Obesity Reports profile →

Peers

Countries citing papers authored by Kamaljit Chatha

Since Specialization

Citations

This map shows the geographic impact of Kamaljit Chatha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamaljit Chatha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamaljit Chatha more than expected).

Fields of papers citing papers by Kamaljit Chatha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kamaljit Chatha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamaljit Chatha. The network helps show where Kamaljit Chatha may publish in the future.

Co-authorship network of co-authors of Kamaljit Chatha

This figure shows the co-authorship network connecting the top 25 collaborators of Kamaljit Chatha. A scholar is included among the top collaborators of Kamaljit Chatha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kamaljit Chatha. Kamaljit Chatha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cardiovascular Disease in the Context of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Comprehensive Narrative Review 2025 ·International Journal of Molecular Sciences ·(unknown), Chris Kite, (unknown), (unknown), Kamaljit Chatha, Nwe Ni Than, Eva Kassi, Ioannis Kyrou, Harpal Randeva	0
2	Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD breakdown → 2024 ·Current Obesity Reports ·(unknown), Chris Kite, (unknown), (unknown), Kamaljit Chatha, (unknown), Μaria Dalamaga, Eva Kassi, Ioannis Kyrou, Harpal Randeva	53
3	Anti-osteoporotic treatments in the era of non-alcoholic fatty liver disease: friend or foe 2024 ·Frontiers in Endocrinology ·Maria Chondrogianni, Ioannis Kyrou, Θεόδωρος Ανδρουτσάκος, Christina‐Maria Flessa, Evangelos Menenakos, Kamaljit Chatha, (unknown), Athanasios G. Papavassiliou, Eva Kassi, Harpal Randeva	4
4	Retinol-binding protein 4 (RBP4) circulating levels and gestational diabetes mellitus: a systematic review and meta-analysis 2024 ·Frontiers in Public Health ·(unknown), Chris Kite, (unknown), (unknown), (unknown), Kamaljit Chatha, Harpal Randeva, Ioannis Kyrou	4
5	Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future 2022 ·International Journal of Molecular Sciences ·(unknown), Ioannis Kyrou, Faizel Osman, (unknown), Harpal Randeva, Kamaljit Chatha	39
6	Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE(-/-) Mice by Activating Autophagy and Reducing ER Stress and Apoptosis breakdown → 2021 ·International Journal of Molecular Sciences ·Narjes Nasiri‐Ansari, (unknown), (unknown), Ioannis Kyrou, Christos S. Mantzoros, Georgios Kyriakopoulos, Antonios Chatzigeorgiou, Vassiliki Kalotychou, (unknown), Kamaljit Chatha, Konstantinos Kontzoglou, Gregory Kaltsas, Athanasios G. Papavassiliou, Harpal Randeva, Eva Kassi	234
7	COVID‑19 and SARS‑CoV‑2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease 2021 ·International Journal of Molecular Medicine ·Periklis Katopodis, (unknown), Julie Davies, Harpal Randeva, Kamaljit Chatha, Marcia Hall, Demetrios�� Spandidos, Vladimir Anikin, Andreas Polychronis, Jan Lukas Robertus, Ioannis Kyrou, Emmanouíl Karteris	23
8	Is There a Link between Bisphenol A (BPA), a Key Endocrine Disruptor, and the Risk for SARS-CoV-2 Infection and Severe COVID-19? 2020 ·Journal of Clinical Medicine ·(unknown), Cristina Sisu, Elisabete Silva, (unknown), Harpal Randeva, Kamaljit Chatha, Ioannis Kyrou, Emmanouíl Karteris	16
9	Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic 2020 ·BMC Medicine ·Ioannis Kyrou, Emmanouíl Karteris, Tim Robbins, Kamaljit Chatha, Fotios Drenos, Harpal Randeva	73
10	Pan‑cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS‑CoV‑2 infection leading to COVID-19 2020 ·International Journal of Oncology ·Periklis Katopodis, Vladimir Anikin, Harpal Randeva, Demetrios�� Spandidos, Kamaljit Chatha, Ioannis Kyrou, Emmanouíl Karteris	36
11	Co‑expression of peripheral olfactory receptors with SARS‑CoV‑2 infection mediators: Potential implications beyond loss of smell as a COVID‑19 symptom 2020 ·International Journal of Molecular Medicine ·(unknown), Marcia Hall, Harpal Randeva, Demetrios�� Spandidos, Kamaljit Chatha, Ioannis Kyrou, Emmanouíl Karteris	31
12	Chemerin in human cardiovascular disease 2018 ·Vascular Pharmacology ·Jaspreet Kaur, Harman S. Mattu, Kamaljit Chatha, Harpal Randeva	39
13	Distinct patterns of hepcidin and iron regulation during HIV-1, HBV, and HCV infections 2014 ·Proceedings of the National Academy of Sciences ·Andrew E. Armitage, Andrea Stacey, Eleni Giannoulatou, (unknown), (unknown), Kamaljit Chatha, Nicola Smith, Xiaojie Huang, Xiao‐Ning Xu, Sant‐Rayn Pasricha, Ning Li, Hao Wu, Craig Webster, Andrew M. Prentice, Pierre Pellegrino, Ian Williams, Phillip Norris, Hal Drakesmith, Persephone Borrow	83
14	LABORATORY DATABASE POPULATION SURVEILLANCE TO IMPROVE DETECTION OF PROGRESSIVE CHRONIC KIDNEY DISEASE 2013 ·Journal of Renal Care ·David M. Kennedy, Kamaljit Chatha, Hugh C. Rayner	10
15	National UK audit of the Short Synacthen^® Test 2010 ·Annals of Clinical Biochemistry International Journal of Laboratory Medicine ·Kamaljit Chatha, Jonathan Middle, Eric S Kilpatrick	21
16	Methylation of the imprinted GNAS1 gene in cell-free plasma DNA: equal steady-state quantities of methylated and unmethylated DNA in plasma 2008 ·Clinica Chimica Acta ·William Puszyk, Kamaljit Chatha, (unknown), Francesco Crea, Robert Old	3
17	B-type natriuretic peptide in reversible myocardial ischaemia: Table 1 2006 ·Journal of Clinical Pathology ·Kamaljit Chatha, (unknown), (unknown), Abubaker Elfatih, Khalid Abozguia, Richard Horton, Simon Dunmore, Rousseau Gama	6
18	Effect of sample tube type and time to separation on in vitro levels of C-reactive protein 2003 ·British Journal of Biomedical Science ·(unknown), Kamaljit Chatha, M.R. Holland, Rousseau Gama	4
19	Ethnic Variation in C-Reactive Protein: UK Resident Indo-Asians Compared with Caucasians 2002 ·European Journal of Cardiovascular Prevention & Rehabilitation ·Kamaljit Chatha, (unknown), Rousseau Gama	15
20	2002 ·Journal of Cardiovascular Risk ·Kamaljit Chatha, (unknown), Rousseau Gama	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact